Together Pharma Ltd (TLV:TGTR)
Israel · Delayed Price · Currency is ILS · Price in ILA 230.00
-8.60 (-3.60%)
Jun 5, 2026, 1:44 PM IDT
Together Pharma Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1.91 | -1.17 | -4.32 | -33.52 | -13.78 |
Depreciation & Amortization | 7.55 | 6.83 | 6.51 | 6 | 5.48 |
Other Amortization | 0.96 | - | 4.35 | 14.3 | 12.25 |
Loss (Gain) From Sale of Assets | - | - | - | - | -0 |
Loss (Gain) on Equity Investments | - | - | - | 0 | - |
Stock-Based Compensation | - | - | - | - | 1.45 |
Other Operating Activities | 4.56 | 0.49 | 17.83 | -0.95 | -13.36 |
Change in Accounts Receivable | 2.02 | -4.36 | -4.28 | -7.44 | 0.42 |
Change in Inventory | -8.5 | -0.67 | -10.5 | 3.4 | -9.8 |
Change in Accounts Payable | -3.62 | 7.17 | 4.41 | 2.96 | -1.15 |
Change in Other Net Operating Assets | 1.7 | -5.45 | 0.82 | 1.51 | -0.16 |
Operating Cash Flow | 6.58 | 2.85 | 14.83 | -13.73 | -18.64 |
Operating Cash Flow Growth | 130.96% | -80.79% | - | - | - |
Capital Expenditures | -1.41 | -1.48 | -0.87 | -0.33 | -1.53 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.01 |
Cash Acquisitions | -1.75 | - | - | - | - |
Sale (Purchase) of Intangibles | -3.72 | -0.16 | -0.15 | -0.41 | -0.1 |
Investment in Securities | - | 0.45 | - | - | - |
Other Investing Activities | - | -0.2 | -0.6 | 33.79 | -27.23 |
Investing Cash Flow | -6.88 | -1.39 | -1.62 | 33.05 | -28.85 |
Long-Term Debt Issued | 116.97 | 100.74 | 78.06 | 50.35 | 38.92 |
Total Debt Issued | 116.97 | 100.74 | 78.06 | 50.35 | 38.92 |
Long-Term Debt Repaid | -112.89 | -97.58 | -92.28 | -80.22 | -11.84 |
Total Debt Repaid | -112.89 | -97.58 | -92.28 | -80.22 | -11.84 |
Net Debt Issued (Repaid) | 4.08 | 3.16 | -14.22 | -29.87 | 27.09 |
Issuance of Common Stock | - | 0.21 | - | 11.53 | 24.73 |
Other Financing Activities | - | - | -0.7 | -0.8 | -2.97 |
Financing Cash Flow | 4.08 | 3.37 | -14.92 | -19.14 | 48.84 |
Foreign Exchange Rate Adjustments | - | 0.02 | 0 | 0.03 | -0.01 |
Net Cash Flow | 3.78 | 4.85 | -1.7 | 0.2 | 1.34 |
Free Cash Flow | 5.17 | 1.37 | 13.97 | -14.07 | -20.17 |
Free Cash Flow Growth | 275.98% | -90.16% | - | - | - |
Free Cash Flow Margin | 4.71% | 1.43% | 15.35% | -45.04% | -167.75% |
Free Cash Flow Per Share | 0.33 | 0.11 | 1.59 | -1.73 | -2.94 |
Cash Interest Paid | 6.26 | 3.95 | 3.98 | 2.23 | 2.74 |
Levered Free Cash Flow | 4.49 | -1.1 | 3.47 | 29.15 | -38.12 |
Unlevered Free Cash Flow | 7.74 | 4.76 | 11.36 | 25.6 | -41.12 |
Change in Working Capital | -8.4 | -3.31 | -9.55 | 0.44 | -10.69 |